|
VCPIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.298000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.118200E-02 |
| Normal-vs-Stage2 |
5.103800E-01 |
| Normal-vs-Stage3 |
9.651400E-01 |
| Normal-vs-Stage4 |
6.714000E-01 |
| Stage1-vs-Stage2 |
8.242400E-02 |
| Stage1-vs-Stage3 |
2.087600E-01 |
| Stage1-vs-Stage4 |
2.060000E-01 |
| Stage2-vs-Stage3 |
5.793600E-01 |
| Stage2-vs-Stage4 |
9.840400E-01 |
| Stage3-vs-Stage4 |
6.785800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.039400E-01 |
| Normal-vs-AfricanAmerican |
4.493000E-01 |
| Normal-vs-Asian |
4.567000E-01 |
| Caucasian-vs-AfricanAmerican |
8.389600E-01 |
| Caucasian-vs-Asian |
8.925600E-01 |
| AfricanAmerican-vs-Asian |
8.588000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.882200E-02 |
| Normal-vs-Female |
3.963000E-01 |
| Male-vs-Female |
1.526330E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.245400E-01 |
| Normal-vs-Extreme_Weight |
1.889990E-02 |
| Normal-vs-Obese |
6.898600E-01 |
| Normal-vs-Extreme_Obese |
1.662830E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.329000E-01 |
| Normal_Weight-vs-Obese |
3.549000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.062400E-01 |
| Extreme_Weight-vs-Obese |
7.103400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.792400E-01 |
| Obese-vs-Extreme_Obese |
2.509000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.633600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.941200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.619800E-02 |
| Normal-vs-Age(81-100Yrs) |
6.398300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.322200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.568000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.773800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.283760E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.681450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.001400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.755900E-02 |
| Normal-VS-Type2 PRCC |
4.738200E-01 |
| Normal-VS-KIRP CIMP |
2.902600E-01 |
| Normal-VS-Unclassified PRCC |
2.868800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.766600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.586100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.510500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.728240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.164200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.440800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.537500E-02 |
| Normal-vs-N1 |
1.960020E-01 |
| Normal-vs-N2 |
5.516800E-01 |
| N0-vs-N1 |
8.722000E-03 |
| N0-vs-N2 |
2.568000E-01 |
| N1-vs-N2 |
8.669400E-01 |
|
|
